Drug intelligence / Profile preview

Chigan

Development stage
Unknown
Lead developer
Peking University Shijia Technology Development
Modality
Small Molecules
Administration
Oral
01

Overview

Chigan is a botanical drug candidate developed by Peking University Shijia Technology Development Co., Ltd. for the treatment of type 2 diabetes mellitus. It is derived from the total saponins of *Gynostemma pentaphyllum* (Jiaogulan), a plant widely used in traditional Chinese medicine. The drug's primary mechanism of action involves the activation of AMP-activated protein kinase (AMPK), a master regulator of cellular energy metabolism. Activation of AMPK leads to increased glucose transporter translocation to the cell membrane, enhancing glucose uptake in skeletal muscle, and simultaneously suppresses the expression of gluconeogenic enzymes in the liver. Chigan has completed Phase 2 and entered Phase 3 clinical trials in China, demonstrating potential as a novel therapy for glycemic control.

Brand names
Chigan
Other names
Gynostemma pentaphyllum total saponins赤甘
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)

Beyond the preview

Go deeper on Chigan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chigan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call